Form 4: Surgery Partners Director Acquires Shares in Recent Transaction
SEC Form 4 Filing
Director Teresa DeLuca acquired 4,192 shares of Surgery Partners, Inc. common stock at a price of $38.16 per share on June 1, 2023.
Summary
- On June 1, 2023, Teresa DeLuca, a director of Surgery Partners, Inc., acquired 4,192 shares of common stock.
- The acquisition price was $38.16 per share.
- Following the transaction, DeLuca directly owns 52,160 shares of Surgery Partners, Inc.
- The shares acquired will vest on June 1, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a director's stock purchase. While insider buying can be seen as a positive signal, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction is specific to Surgery Partners and its director.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/01/2023 | Date of stock acquisition by Teresa DeLuca |
| 06/01/2024 | Vesting date for the acquired shares |
| 04/05/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.